Eribulin Impurity 15 | CAS 85324-18-1 - Request Quote
Eribulin Impurity 15
| SZ CAT No: | SZ-E065019 |
| CAS No | 85324-18-1 |
| Mol.F. | C8H21ClOSi2 |
| Mol.Wt. | 224.9 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Eribulin Impurity 15 is chemically 1-(Tert-butyl)-3-chloro-1,1,3,3-tetramethyldisiloxane. Eribulin Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Eribulin Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Eribulin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 85324-18-1
Purchase 85324-18-1
Order 85324-18-1
Enquire 85324-18-1
price of 85324-18-1
85324-18-1 Supplier
85324-18-1 Manufacturer
85324-18-1 Exporter
buy high quality Eribulin Impurity 15
Purchase Eribulin Impurity 15
Eribulin Impurity 15 suppliers
Eribulin Impurity 15 manufacturers
Eribulin Impurity 15 price
Order Eribulin Impurity 15
Enquire Eribulin Impurity 15
Eribulin Impurity 15 cost
Eribulin Impurity 15 Supplier
Eribulin Impurity 15 Distributor
Eribulin Impurity 15 for Method Validation
Eribulin Reference Standard
Eribulin Impurity 15 for ANDA Filing
Eribulin Impurity 15 for Forced Degradation Studies
Eribulin Impurity 15 Identification Standards
Eribulin Impurity 15 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


